List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 338 studies with search of: "Lamivudine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)
Condition: Chronic Hepatitis B
Interventions: Drug: Lamivudine plus Polyethylene glyco-interferon alfa-2b;   Drug: Lamivudine
2 Active, not recruiting Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine
Condition: HIV-1
Interventions: Drug: Maraviroc + Zidovudine/Lamivudine;   Drug: Efavirenz + Zidovudine/Lamivudine;   Drug: Maraviroc (UK-427,857) + Zidovudine/Lamivudine
3 Completed A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients
Condition: HIV Infection
Interventions: Drug: abacavir/lamivudine;   Drug: abacavir;   Drug: lamivudine
4 Active, not recruiting Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
Condition: HIV Infections
Interventions: Drug: Abacavir/Lamivudine;   Drug: Atazanavir;   Drug: Efavirenz;   Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Ritonavir;   Drug: Abacavir/Lamivudine placebo;   Drug: Emtricitabine/Tenofovir disoproxil fumarate placebo
5 Active, not recruiting Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
Condition: HIV Infection
Interventions: Drug: ABC/3TC + ATV/r x 36wks followed by ABC/3TC + ATV x 48wks;   Drug: ABC/3TC + ATV/r x 36wks followed by ABC/3TC + ATV/r x 48wks
6 Recruiting Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children
Condition: HIV Infections
Interventions: Drug: Lamivudine, nevirapine, and stavudine fixed-dose tablet;   Drug: Lamivudine;   Drug: Nevirapine;   Drug: Stavudine
7 Not yet recruiting Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand
Condition: HIV Infections
Interventions: Drug: GPO-Vir Z30 tablet;   Drug: Lamivudine;   Drug: Nevirapine;   Drug: Zidovudine
8 Completed KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
Condition: HIV Infection
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir;   Drug: KALETRA;   Drug: EPIVIR;   Drug: Ziagen;   Drug: Abacavir/Lamivudine;   Drug: Fosamprenavir
9 Not yet recruiting Efficacy and Safety of Infant Peri-Exposure Prophylaxis With Lamivudine to Prevent HIV-1 Transmission by Breastfeeding
Condition: HIV Infections
Interventions: Drug: lamivudine (3TC);   Drug: Placebo
10 Completed New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects
Condition: HIV Infection
Interventions: Drug: abacavir/lamivudine;   Drug: abacavir;   Drug: lamivudine;   Drug: tenofovir
11 Withdrawn Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: Lamivudine;   Drug: Telbivudine
12 Recruiting Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir;   Drug: Lamivudine
13 Recruiting Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir;   Drug: Lamivudine
14 Recruiting Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir;   Drug: Lamivudine
15 Active, not recruiting Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Efavirenz;   Drug: Lamivudine;   Drug: Stavudine
16 Recruiting Efficacy of Clevudine Plus Lamivudine for Lamivudine-Resistant Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: adefovir;   Drug: clevudine;   Drug: lamivudine
17 Recruiting Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-Resistant Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: combination of lamivudine+adefovir vs entecavir
18 Recruiting Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-Resistant Virus
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir;   Drug: Tenofovir;   Drug: Adefovir;   Drug: Lamivudine
19 Recruiting Preventing Sexual Transmission of HIV With Anti-HIV Drugs
Condition: HIV Infections
Interventions: Drug: Atazanavir;   Drug: Didanosine;   Drug: Efavirenz;   Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Lamivudine;   Drug: Lopinavir/Ritonavir;   Drug: Nevirapine;   Drug: Stavudine;   Drug: Tenofovir disoproxil fumarate;   Drug: Zidovudine/Lamivudine
20 Completed Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Delavirdine mesylate;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services